Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
- PMID: 37009462
- PMCID: PMC10062602
- DOI: 10.3389/fnagi.2023.1130253
Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
Abstract
There is a close relationship between Alzheimer's disease (AD) and diabetes mellitus (DM), and the link between the two is often referred to as type 3 diabetes mellitus (T3DM). Many natural bioactive compounds have shown the potential to treat AD and diabetes. We mainly review the polyphenols represented by resveratrol (RES) and proanthocyanidins (PCs) and alkaloids represented by berberine (BBR) and Dendrobium nobile Lindl. alkaloids (DNLA) from the perspective of T3DM to review the neuroprotective effects and molecular mechanisms of natural compounds in AD.
Keywords: Alzheimer's disease; alkaloids; antidiabetic medication; natural bioactive compounds; polyphenols; traditional Chinese medicines; type 2 diabetes mellitus; type 3 diabetes mellitus.
Copyright © 2023 Huang, Huang, Mao, Shi and Qiu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Alzheimer's Disease International (2019). World Alzheimer Report 2019: Attitudes to Dementia [Online]. Available online at: https://www.alz.co.uk/research/world-report-2019 (accessed September 20, 2019).
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
